Febuxostat

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1637 publications

Synthesis of Primary Thioamides by the Insertion of CS2 into Aldoximes.

Synthesis of Primary Thioamides by the Insertion of CS2 into Aldoximes.

Journal: Organic letters

Published: June 08, 2026

Febuxostat enhances the anti-tumor efficacy of 2-fluoroadenine and 5'-methylthioadenosine in MTAP-deleted cancer.

Febuxostat enhances the anti-tumor efficacy of 2-fluoroadenine and 5'-methylthioadenosine in MTAP-deleted cancer.

Journal: bioRxiv : the preprint server for biology

Published: June 04, 2026

Correction: Comprehensive Review on Febuxostat for Hyperuricemia with Gout: Insights from Current Practice and Clinical Trials.

Correction: Comprehensive Review on Febuxostat for Hyperuricemia with Gout: Insights from Current Practice and Clinical Trials.

Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

Published: May 18, 2026

Treat-to-Target Urate-lowering Therapy: Lessons Learned from the STOP Gout Study.

Treat-to-Target Urate-lowering Therapy: Lessons Learned from the STOP Gout Study.

Journal: Current rheumatology reports

Published: April 16, 2026

Targeted degradation of xanthine oxidase via PROTAC technology for the treatment of hyperuricaemia.

Targeted degradation of xanthine oxidase via PROTAC technology for the treatment of hyperuricaemia.

Journal: Journal of materials chemistry. B

Published: April 14, 2026

DMARDs and gout therapy in patients with chronic arthritis and end-stage renal disease: a descriptive guide.

DMARDs and gout therapy in patients with chronic arthritis and end-stage renal disease: a descriptive guide.

Journal: Acta clinica Belgica

Published: April 05, 2026

Febuxostat alleviates testicular dysfunction induced by cyclophosphamide in rats via modulation of pyroptosis and mTOR autophagy axis.

Febuxostat alleviates testicular dysfunction induced by cyclophosphamide in rats via modulation of pyroptosis and mTOR autophagy axis.

Journal: Scientific reports

Published: March 31, 2026

Allopurinol and Febuxostat Hypersensitivity in a Patient with Young Onset Gout: A Case Report.

Allopurinol and Febuxostat Hypersensitivity in a Patient with Young Onset Gout: A Case Report.

Journal: Acta medica Philippina

Published: March 18, 2026

A real-world retrospective cohort study comparing brand-name febuxostat (feburic) and generic febuxostat (feuri).

A real-world retrospective cohort study comparing brand-name febuxostat (feburic) and generic febuxostat (feuri).

Journal: Science progress

Published: March 10, 2026

Response to "Febuxostat and cardiovascular outcomes: Methodological considerations and future directions".

Response to "Febuxostat and cardiovascular outcomes: Methodological considerations and future directions".

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: March 08, 2026

Metformin repurposing in gout: enhancing febuxostat efficacy through anti-inflammatory and metabolic modulation: a randomized controlled double-blind study.

Metformin repurposing in gout: enhancing febuxostat efficacy through anti-inflammatory and metabolic modulation: a randomized controlled double-blind study.

Journal: Inflammopharmacology

Published: March 06, 2026

Therapeutic Strategies for Hyperuricemia: From Small-Molecule Inhibitors to RNA Therapeutics.

Therapeutic Strategies for Hyperuricemia: From Small-Molecule Inhibitors to RNA Therapeutics.

Journal: ACS pharmacology & translational science

Published: March 06, 2026

Showing 1-12 of 1,637

Last Updated: 06/30/2026